Medicare Will Pay for Avastin and Provenge
Medicare will keep paying for the drug Avastin to fight breast cancer even though an FDA panel has recommended that the medication no longer be sold as a treatment for breast cancer.
Copyright 2012 Inergize Digital. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.